It is a truth universally acknowledged that a patient lacking a hormone must be in want of replacement. Or is it? Not, it would seem, when neither the role of the hormone nor its biochemical deficiency can be simply defined, and the replacement therapy is a daily injection costing £3000-5000 a year. Pure and plentiful supplies of recombinant human growth hormone have been available since the late 1 980s. The pharmaceutical companies are enthusiastic to fund research looking for legitimate new markets. Opinions of endocrinologists on the subject of growth hormone treatment for growth hormone deficient adults (GHDAs) range from the evangelical to the cynical. Meanwhile, less scrupulous operators promote its use as an elixir of life for normal elderly people and a potent yet undetectable drug of abuse in sport. From jacket sleeve to preface to introduction, it is clear that the editors of this book are keen advocates of growth hormone replacement therapy. They have assembled an impressive list of contributors, including many international experts.
The first part covers the physiology of the growth hormone (GH) insulin-like growth factor (IGF) axis. This is a complex system with great species differences. Associations are easy to describe, but plausible hypotheses to explain them are more elusive. Werner Blum gives a very clear and up-to-date explanation of the IGF system, its control and its uses in the diagnosis of growth hormone deficiency (GHD) in children and adults. We liked his teleological proposition that IGF-I integrates information about the wellbeing of the organism (from its nutritional state and activation of its immune system) to adapt cellular activities such as proliferation to its situation. The chapter by E Rudolf Froesch and others includes an interesting section on the experimental use of IGF-I in catabolic conditions and as a treatment for diabetes mellitus.
The next two parts of the book make a somewhat artificial division between 'Diagnostic and clinical aspects of GHD in children and adults' and 'GH replacement therapy in GHDAs'. The chapter by Ross Cuneo, Franco Salomon and Peter Sonksen touches on some of the problems surrounding the syndrome of GHD in adults. The stimulated GH peak following an insulin tolerance test (ITT) may show that a patient has mild biochemical GHD, but such levels overlap with those found in the normal population with increasing age. Many of the studies to date have lacked the power to detect potential effects, being too small or of too short a duration. It is difficult to justify lifelong treatment on the basis of studies lasting less than a year. With some trials being open or uncontrolled, and a nonhomogeneous patient group (including patients with adult and childhood onset GHD on a variety of other hormone replacement regimens) it is hardly surprising that the results are often inconclusive or contradictory. Many studies also examine markers of potentially beneficial effects, such as bone mineral density and biochemical bone markers for fracture rate, or lipid profile and per cent body fat for cardiovascular morbidity. Even these distinguished authors include anecdotal case reports, such as a dramatically improved cardiac output in a patient with cardiomyopathy treated with GH.
David Hoffman and Ken Ho discuss the diagnosis of GHD in adults. The various ways of evaluating GH status, such as measurement of peak GH responsc to provocative stimuli, spontaneous GH levels in repeated samples over extended periods of time, or IGF-I levels, do not give concordant results. The stimulation tests most commonly used were developed for use in children with short stature. Threshold values in adults are derived empirically and vary over a 10-fold range between different centres. This is compounded by variation between different GH assays, and the effects on GH levels of age, gender, adiposity and other hormone replacement therapy. UK readers may find the use throughout the book of GH levels quoted in ng/mL rather than mU/L adds to their confusion.
The chapter by Stephen Shalet and others on monitoring of GH replacement therapy makes the point that, whilst in children height is an easy and cheap marker of the efficacy of GH treatment, there is no equivalent measure in adults. The end points are often ill-defined or complex and expensive to monitor outside the research setting. The guidelines they give for assessing the patient are clear, if verging on the didactic. These are not supported by evidence or otherwise justified, but they clearly represent the clinical experience of a group who have treated large numbers of GHDAs. They emphasize that monitoring is important both to assess side effects and efficacy of treatment on an individual basis and to develop pooled databases of information about GH treatment.
It is interesting to learn more details about the effects of GH replacement therapy in GHDAs. These include an increased glomerular filtration rate, possibly mediated by nitric oxide, and improved thermoregulation through GH stimulation of the eccrine sweat glands. Thord Rosen mentions the increase in lipoprotein (a) [Lp(a)I levels seen with GH treatment. Though other changes in the lipid profile are generally favourable, Lp(a) has atherogenic and thrombotic effects. The overall effects of GH on the premature cardiovascular mortality associated with hypopituitarism remain to be seen.
The psychosocial and central nervous system (CNS) effects of GH treatment described by Bengtsson and colleagues are in many ways the most interesting. GH treatment of GHDAs can improve quality of life and psychological well-being. The mechanism is probably multifactorial. An improved sleep pattern and increased exercise capacity may contribute to the 'feel good factor'. Direct effects on the CNS are possible: both GH and IGF-I receptors are found in the brain; recombinant human GH does cross the blood brain barrier; and changes in the composition of the cerebrospinal fluid after GH treatment are similar to those seen after treatment with antidepressants.
The final chapter is devoted to GH and ageing. To be sure, aspects of the ageing process are similar to states of hormone deficiency or excess. However, quite apart from the ethical issues, the theoretical benefits of GH treatment in the normal elderly do not seem to have been substantiated in practice.
Simple exercise training is more beneficial, less costly, and avoids the side-effects of GH treatment in this age group, which can include hypertension, raised plasma glucose and a possible cancer risk.
This book provides an overview of research on GH replacement therapy in GHDAs, with a positive gloss. For those involved in the field, it offers little that is novel or startling. A few areas of current interest are not mentioned or not discussed in depth. These include the development of growth hormone releasing peptides, both for diagnostic and therapeutic purposes. Since these can be administered orally or nasally, they could well replace ITTs and daily injections of GH. The pathophysiology of GH in catabolic conditions such as burns and postoperative patients, and its clinical use (mostly undertaken by surgeons and intensivists at the moment), could well start to involve endocrinologists as members of multidisciplinary teams. For the clinician managing GHDAs, practical guidelines on who to treat, who not to treat, dosage regimens and so forth are not made explicit. Economic considerations and QALYs gained by GH treatment are also not discussed. The book would benefit from more figures to replace some of the text, and there are a few places where the non-English-speaking origin of some of the contributors leads to oddities of style.
Trials of GH treatment of GHDAs published to date have lasted only 3-5 years at most. Gradually the results of long studies looking at hard endpoints and comparing dosage regimens will come out. We will then have a clearer idea of which patients genuinely benefit from GH more than they would from an annual gratuity of the cost of their treatment. This group will probably be those with a severe biochemical deficiency combined with a clinical picture in keeping with the GHD syndrome, in particular impaired psychological wellbeing. If nITs and daily injections of GH are superseded by simpler methods of diagnosis and treatment, this will remove considerable obstades for both the clinician and the patient contemplating GH replacement therapy. Perhaps in the future such treatment will become as routine as replacement therapy with corticosteroids, thyroxine and sex steroids. Anyone who has had to take up the challenge of the Primary FRCS would appreciate a book like this. The first edition came out in 1986 and I used it for the exam myself. Times have changed, and the new curriculum established for basic surgical training has brought sweeping changes in the scope and level of knowledge required. Additionally, those taking the exit (Part 3) examinations are now expected to retain a good understanding of basic sciences.
The aim of this new version is to provide a 'look up' text covering a wide range of surgically applicable basic science. It is arranged in alphabetical order, running from abscess to Zollinger-Ellison syndrome. The index is comprehensive and helpful with an accompanying index of the biographical notes so loved by examiners (Ah yes, but who was Krukenburg?). This section could be more detailed, however. There is also an accompanying appendix of normal values. The text runs through a range of basic sciences with no glaring omissions. It is written in an instructive manner with each topic divided into a 'surgical sieve' where possible.
In summary I have no hesitation in recommending this text to surgeons in training, particularly those in the earlier stages taking the new AFRCS/MRCS exams. My only real criticism is that it is too big for the average overcoat/jacket pocket-otherwise it would be the ideal book for those rare moments of peace on the bus. M G Dilkes Royal London Hospital, Whitechapel, London, England Medical Informatics: The Essentials
FT de Dombal
Book with floppy disk Price £14.99 ISBN 0 7506 21621 Oxford: Butterworth Heinemann, 1996 Medical Informatics is intended for the noncomputer-literate amongst medical professionals who wish to find out what computer technology can do for them. Professor de Dombal makes his case for the use of computers by describing the necessity for analysis of medical data and the difficulties encountered due to the 'fuzziness' of medical information. The hardware from which computer systems are constructed is described in a simple, concise but comprehensive way, enabling even those who have never seen a computer to understand what goes on inside. The use of computer networks as well as 'multimedia' is covered. Computer journals and books tend to contain obscure terms and the author defines several in his text, including bits, bytes and operating system. He describes how to switch on a computer and get it to do the things that the user really wants rather than what the computer thinks it should be doing. For those who have never used a computer he indudes a description of what word processors, spreadsheets, databases and electronic mail can do. Graphical user interfaces are also mentioned, with particular emphasis on the Windows operating system.
The basic description of computers, networks and the software that might be used takes up much of the first half of the book. The second half concentrates on how medical information can be stored, manipulated and analysed with a computer. Included are aspects of medical education, coding of data and a wide range of computer programs used in clinical practice. de Dombal also discusses the technical, legal and ethical implications of storing patient data on a computer system. The book is accompanied by a floppy disk that is intended to provide further insight into the way computers work and collaborate with each other. Unfortunately, the disk received with my review book was entirely blank.
Medical Informatics is aimed at those who have virtually no knowledge of modem computing methods and want to know what everyone is talking about. It is not intended to teach the use of any particular computer system or application program. It discusses, in a comprehensible but not oversimplistic way, many aspects of modern medical computing that are invaluable to healthcare professionals.
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